Could the onset age of Alzheimer’s disease be modified?

Patients carrying genes which place them at risk of developing Alzheimer’s disease (AD) can be identified by genetic testing prior to the onset of the disorder, however there are currently no therapies to treat AD. Christine Van Broeckhoven, PhD, DSc from the Neurodegenerative Brain Diseases Group, VIB, Antwerp, Belgium talks to us about the novel genetic risk factor for AD, ABCA7. It appears that the onset age can be influenced, and Dr Broeckhoven explains how understanding the mechanism behind this could benefit AD patients. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.

Share this video